SCTX · Scribe Therapeutics, Inc. · Fails to Deliver
$33.00
+0.86 (+2.68%)
At close · Sep 18
Going-concern doubt
— cleared Sep 2, 2026
The latest filing states the doubt was alleviated.
“Substantial doubt about our ability to continue as a going concern existed as of June 30, 2026 and was alleviated as a result of the completion of our initial public offering and concurrent private placement, which resulted in aggregate net proceeds of approximately $140.7 million.”View the 10-Q filed Sep 2, 2026
Market Cap
$578.48M
Shares
18.93M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-27 | 47 | $31.70 | $1,490 |
| 2026-08-24 | 2,763 | $34.13 | $94,301 |
| 2026-08-21 | 10,204 | $32.83 | $334,997 |
| 2026-08-12 | 58 | $23.44 | $1,360 |
| 2026-08-05 | 1,465 | $22.06 | $32,318 |
| 2026-08-03 | 599 | $19.48 | $11,669 |
| 2026-07-30 | 26,121 | $18.36 | $479,582 |
| 2026-07-28 | 55 | $18.97 | $1,043 |
| 2026-07-27 | 23,154 | $21.65 | $501,284 |
Showing 1–9 of 9 settlements